Improving cancer detection using advanced light technology and machine learning
Metasurface enhanced and machine learning aided spectrochemical liquid biopsy
This study is working on a new, easy way to find cancer markers in body fluids without needing invasive procedures, using advanced technology to make early detection and monitoring of cancer more accurate and convenient for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11030790 on NIH RePORTER |
What this research studies
This research focuses on developing a new method for detecting cancer-related biomarkers in body fluids through a non-invasive liquid biopsy approach. By utilizing advanced spectrochemical techniques, such as Raman and infrared spectroscopy, combined with machine learning, the project aims to enhance the sensitivity and accuracy of cancer detection. The innovative use of electromagnetic metasurfaces is expected to improve the performance of these diagnostic tools, making them more effective for early cancer detection and patient monitoring. Ultimately, the goal is to create a portable and user-friendly platform that can be used in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for cancer or those undergoing monitoring for cancer recurrence.
Not a fit: Patients with cancers that are not detectable through liquid biopsy methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate cancer detection, potentially improving survival rates for patients.
How similar studies have performed: Other research has shown promise in using advanced spectrochemical techniques for cancer detection, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Yesilkoy, Filiz — University of Wisconsin-Madison
- Study coordinator: Yesilkoy, Filiz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.